FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:11/03/97ISR Number: 100000064Report Type:Ex
Use of COX-2 inhibitors for the treatment of affective disorders - Patent 1627639
Glianimon® 2 mg / 5 mg / 10 mg, Tabletten
Glianimon 2mg tabletten bei medizinfuchs.de
Antipsychotics for treatment of delirium in hospitalised non-ICU patients
Glianimon generic. Price of glianimon. Uses, Dosage, Side effects
9. Präparatehinweise
Use of COX-2 inhibitors for the treatment of affective disorders - Patent 1627639
PDF) Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany
Neuroleptikum – Wikipedia
Use of COX-2 inhibitors for the treatment of affective disorders - Patent 1627639